[ad_1]
A research study by scientists at Wuhan University in China revealed the efficacy and safety of a drug. avigan Japanese to treat patients with coronavirus, for a clinical recovery rate of 7 days, after taking the drug.
Where the experiment was conducted on patients who confirmed the coronavirus at 3 hospitals in Wuhan, China, the epicenter of the outbreak in late December.
The initial result was published in his diary. medrxiv The scientific study indicated a clinical recovery rate over 7 days and included the duration of fever, time to relieve cough, additional oxygen therapy, or respirator survival rate, and the ages of the participants ranged from 18 years or more randomly to receive favipiravir Or safety data was collected for an additional week of follow-up.
120 HIV patients who did not suffer from chronic diseases underwent medication favipiravir The results showed a 7-day clinical recovery rate of 71.43%.
Results included the success of the Japanese drug in relieving symptoms of fever and cough in crown patients with high blood pressure or diabetes.
The results of the experiment revealed that in normal Corona virus patients who had not previously been treated with antivirals, it could be considered favipiravir As a preferred treatment due to the high clinical recovery rate over 7 days and a more effective reduction in fever, except for some adverse effects associated with viruses, this study was recorded in the Chinese Clinical Trial Register No. ChiCTR200030254.
Experts emphasized that corona virus and influenza viruses have a similar symptom of illness, and clinical manifestations are dominated by respiratory symptoms that appear as a wide range of illnesses, from symptoms or mild to severe illness and death, leading to led doctors to use the Japanese drug that was made to eliminate the flu
The experiment was carried out with a medicine. aviga The Japanese have 240 coronavirus patients in three hospitals, 120 patients from one hospital. Zhongnan At Wuhan University, 88 patients are hospitalized. Leishenshan , And 32 patients from Third People’s Hospital in Hubei.
